Century Therapeutics, Inc. (IPSC)
USD 1.05
(-10.68%)
USD 1.05
(-10.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 2.23 Million | 5.19 Million | - | - | - |
| Cost of Revenue | 13.04 Million | 10.07 Million | 4.58 Million | 1.75 Million | 249 Thousand |
| Gross Profit | -10.8 Million | -4.87 Million | -4.58 Million | -1.75 Million | -249 Thousand |
| Operating Expenses | 56.07 Million | 139.03 Million | 94.88 Million | 49.17 Million | 20.03 Million |
| Selling, General and Administrative Expenses | 34.7 Million | 31.85 Million | 19.23 Million | 9.49 Million | 5.76 Million |
| Research and Development Expenses | 92.71 Million | 107.17 Million | 75.64 Million | 39.68 Million | 14.26 Million |
| Other Expenses | 21.36 Million | 4.42 Million | 377 Thousand | 704 Thousand | 1.21 Million |
| Cost and Expenses | 148.78 Million | 139.03 Million | 94.88 Million | 49.17 Million | 20.03 Million |
| Operating Income | -146.54 Million | -133.83 Million | -94.88 Million | -53.89 Million | -245.97 Million |
| Interest Expense | 540 Thousand | 1.1 Million | 1.27 Million | 381 Thousand | - |
| Income Tax Expense | 1.88 Million | 91 Thousand | 43 Thousand | 1.08 Million | 1.21 Million |
| Earnings before Tax | -134.79 Million | -130.84 Million | -95.78 Million | -53.57 Million | -244.76 Million |
| Net Income | -136.67 Million | -130.93 Million | -95.82 Million | -54.66 Million | -245.97 Million |
| Earnings Per Share Basic | -2.30 | -2.27 | -1.74 | -1.00 | -4.49 |
| Earnings Per Share Diluted | -2.30 | -2.27 | -1.74 | -1.00 | -4.49 |
| Weighted Average Shares Outstanding | 59.31 Million | 57.75 Million | 55 Million | 54.82 Million | 54.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 59.31 Million | 57.75 Million | 55 Million | 54.82 Million | 54.82 Million |
| Gross Margin | -4.84 | -0.94 | - | - | - |
| EBIT Margin | -54.23 | -23.33 | - | - | - |
| Profit Margin | -61.15 | -25.18 | - | - | - |
| EBITDA | -121.2 Million | -119.34 Million | -89.92 Million | -51.44 Million | -19.78 Million |
| Earnings Before Tax Margin | -65.57 | -25.74 | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 791 Thousand | 771 Thousand | 855 Thousand | 268 Thousand | 2.23 Million | 148 Thousand |
| Cost of Revenue | - | 3.46 Million | 3.22 Million | 3.55 Million | 13.04 Million | 1.78 Million |
| Gross Profit | 791 Thousand | -2.69 Million | -2.37 Million | -3.28 Million | -10.8 Million | -1.63 Million |
| Operating Expenses | 35.58 Million | 32.84 Million | 28.93 Million | 27.33 Million | 114.37 Million | 31.77 Million |
| Selling, General and Administrative Expenses | 8.35 Million | 9.08 Million | 8.74 Million | 5.03 Million | - | 8.98 Million |
| Research and Development Expenses | 27.22 Million | 23.75 Million | 20.19 Million | 22.29 Million | - | 22.78 Million |
| Other Expenses | - | -12 Thousand | 11 Thousand | -15 Thousand | -383 Thousand | 12 Thousand |
| Cost and Expenses | 35.58 Million | 36.3 Million | 32.16 Million | 30.88 Million | 127.41 Million | 31.77 Million |
| Operating Income | -34.78 Million | -35.53 Million | -31.3 Million | -30.61 Million | -125.18 Million | -35.62 Million |
| Interest Expense | - | - | - | -1.08 Million | 540 Thousand | - |
| Income Tax Expense | 8000.00 | 22 Thousand | 1000.00 | -869 Thousand | 1.88 Million | 592 Thousand |
| Earnings before Tax | -31.23 Million | -31.18 Million | -28.06 Million | -40.26 Million | -134.79 Million | -32.12 Million |
| Net Income | -31.22 Million | -31.2 Million | -28.06 Million | -39.39 Million | -136.67 Million | -32.72 Million |
| Earnings Per Share Basic | -0.00 | -0.38 | -0.45 | -0.66 | - | -0.55 |
| Earnings Per Share Diluted | -0.00 | -0.38 | -0.45 | -0.66 | - | -0.55 |
| Weighted Average Shares Outstanding | 84.7 Billion | 82.09 Million | 62.29 Million | 59.88 Million | 59.31 Million | 59.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 84.7 Billion | 82.09 Million | 62.29 Million | 59.88 Million | 59.31 Million | 59.44 Million |
| Gross Margin | 1.00 | -3.49 | -2.77 | -12.25 | -4.84 | -11.07 |
| EBIT Margin | -43.98 | -41.60 | -32.85 | -100.99 | - | -190.05 |
| Profit Margin | -39.48 | -40.48 | -32.82 | -147.01 | -61.15 | -221.08 |
| EBITDA | -34.78 Million | -32.07 Million | -28.08 Million | -27.06 Million | - | -28.12 Million |
| Earnings Before Tax Margin | -43.98 | -46.09 | -36.62 | -114.24 | -56.01 | -240.72 |
DXC
AJAX
HYFXF
TPII
AIRS
GGAL